Related Experiment Video
Updated: Dec 18, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases
Alicia M Casey1, Robin R Deterding2, Lisa R Young3
1Division of Pulmonary Medicine, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts.
Insights
Children's interstitial and diffuse lung diseases are rare, serious lung conditions in kids. Research networks are improving understanding and treatment for these challenging pediatric lung disorders.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Interstitial Lung Disease
Background:
- Children's interstitial and diffuse lung diseases (ChILD) are rare, serious lung conditions in children.
- These diseases present with diffuse pulmonary infiltrates and respiratory symptoms, leading to high morbidity and mortality.
- Limited understanding of natural history and directed therapies pose significant challenges for clinicians.
Purpose of the Study:
- To review the progress in the field of pediatric interstitial and diffuse lung diseases.
- To highlight successes achieved through collaborative research efforts.
- To provide an overview of past and current advancements in ChILD.
Main Methods:
- Literature review of research on Children's Interstitial and Diffuse Lung Disease.
- Analysis of successes from the Children's Interstitial Lung Disease Foundation Research Network and Foundation.
- Synthesis of current knowledge and future directions in ChILD research.
Main Results:
- Establishment of collaborative networks has driven significant progress in ChILD research.
- Increased understanding of the complexities of these rare pediatric lung diseases.
- Development of a growing body of knowledge in this rapidly evolving field.
Conclusions:
- Collaborative research networks are crucial for advancing ChILD understanding and care.
- Continued research is essential to address the unmet needs in pediatric interstitial lung diseases.
- The field of ChILD has seen notable successes, with ongoing potential for further breakthroughs.
Abstract:
Children's interstitial and diffuse lung diseases are a diverse group of rare lung disorders that present in childhood with diffuse pulmonary infiltrates and respiratory signs and symptoms. Children with these disorders face high morbidity and mortality and their families must cope with overwhelming uncertainty. Physicians caring for these patients are challenged by a paucity of directed therapies, or even understanding of natural history. Through the establishment of the Children's Interstitial Lung Disease Foundation Research Network and the Children's Interstitial Lung Disease Foundation significant progress has been made through collaboration and research. This review outlines the past and current successes in the new and rapidly growing field of Children's Interstitial and Diffuse Lung Disease.
More Related Videos
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Preclinical Development: Overview
Drug Discovery: Overview
Clinical Trials: Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Sex-linked Disorders